Laser Megajoule performance status.

The Laser Megajoule (LMJ) is among the most energetic inertial confinement fusion laser facilities in the world, together with the National Ignition Facility (NIF) in the USA. The construction of the facility began back in 2003, and the first photons were emitted by the laser bundle #28 in 2014. Today, 11 laser bundles consisting of 88 large aperture 0.

Few-cycle optical vortices for strong-field physics.

We report on the generation of optical vortices with few-cycle pulse durations, 500μJ per pulse, at a repetition rate of 1 kHz. To do so, a 25 fs laser beam at 800 nm is shaped with a helical phase and coupled into a hollow-core fiber filled with argon gas, in which it undergoes self-phase modulation. Then, 5.

Photon Pathways and the Nonperturbative Scaling Law of High Harmonic Generation.

High harmonic generation (HHG) has become a core pillar of attosecond science. Traditionally described with field-based models, HHG can also be viewed in a parametric picture, which predicts all properties of the emitted photons, but not the nonperturbative efficiency of the process. Driving HHG with two noncollinear beams and deriving analytically the corresponding yield scaling laws for any intensity ratio, we herein reconcile the two interpretations, introducing a generalized photonic description of HHG.

Nonlinear up-conversion of a polarization Möbius strip with half-integer optical angular momentum.

Symmetries and conservation laws of energy, linear momentum, and angular momentum play a central role in nonlinear optics. Recently, paraxial light fields with nontrivial topology have been attracting a keen interest. Despite not being eigenstates of the orbital and spin angular momenta (OAM and SAM), they are eigenstates of the generalized angular momentum (GAM) operator-a mixture of the OAM and SAM operators with fractional eigenvalues.

The COPD Foundation's COPD360Net Initiative Approach to Patient-Centric Drug Development: A Case Study in Using Patient Surveys to Inform New Treatments for Viral Respiratory Infections.

Patient-centric drug development is crucial to creating treatments that address unmet patient needs but is often ignored. The COPD Foundation's COPD360Net includes a multistakeholder approach for operationalizing patient-centric development of treatments where patients, caregivers, scientists, and clinicians review opportunities based on scientific merit, potential to address an unmet need, and feasibility of adoption. COPD360Net deploys large-scale online community surveys to review profiles of potential therapies based on those criteria.